<SEC-DOCUMENT>0001104659-16-110481-index.html : 20160408 <SEC-HEADER>0001104659-16-110481.hdr.sgml : 20160408 <ACCEPTANCE-DATETIME>20160408080810 ACCESSION NUMBER: 0001104659-16-110481 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160408 FILED AS OF DATE: 20160408 DATE AS OF CHANGE: 20160408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 161561340 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>a16-8156_16k.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: a16-8156_16k.htm
</DOCUMENT> </SEC-DOCUMENT>